About deCODE Genetics
deCODE Genetics is a company based in Reykjavik (Iceland) founded in 1996 was acquired by Amgen in December 2012.. deCODE Genetics has completed 1 acquisition, including UVS. deCODE Genetics offers products and services including Genome Analysis Platform and AI Splicing Prediction Tool. deCODE Genetics operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
- Headquarter Reykjavik, Iceland
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of deCODE Genetics
deCODE Genetics offers a comprehensive portfolio of products and services, including Genome Analysis Platform and AI Splicing Prediction Tool. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for identifying genetic variations linked to human diseases
Method to enhance accuracy of RNA splicing predictions in genetics
Unlock access to complete
Funding Insights of deCODE Genetics
- Total Funding Total Funding
- Total Rounds 14
- Last Round Grant — $702,262
-
First Round
First Round
(17 May 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Grant - deCODE Genetics | Valuation |
investors |
|
| Jan, 2020 | Amount | Grant - deCODE Genetics | Valuation |
investors |
|
| Jan, 2019 | Amount | Grant - deCODE Genetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in deCODE Genetics
deCODE Genetics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Amgen, HHS and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Developer of pharmaceutical products for treating multiple diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by deCODE Genetics
deCODE Genetics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include UVS. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cancer research is conducted via population genomic studies.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - deCODE Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Decode Genetics Comparisons
Competitors of deCODE Genetics
deCODE Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing and genomics services are provided globally.
|
|
| domain | founded_year | HQ Location |
Genome sequencing, analysis, and genetic screening services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Decode Genetics
Frequently Asked Questions about deCODE Genetics
When was deCODE Genetics founded?
deCODE Genetics was founded in 1996 and raised its 1st funding round 11 years after it was founded.
Where is deCODE Genetics located?
deCODE Genetics is headquartered in Reykjavik, Iceland.
What does deCODE Genetics do?
Founded in 1996 in Reykjavik, Iceland, operations in the bioinformatics sector are conducted by deCODE Genetics. Genetic variations linked to diseases including cardiovascular, psychiatric, and cancer conditions are identified through a platform supported by extensive genotypic and medical data from 160,000 Icelandic volunteers. A genealogical database spanning nearly 1,000 years is maintained, facilitating large-scale disease studies with minimized bias and genotype imputation capabilities.
Who are the top competitors of deCODE Genetics?
deCODE Genetics's top competitors include Novogene Corporation, Source BioScience and Genewiz.
What products or services does deCODE Genetics offer?
deCODE Genetics offers Genome Analysis Platform and AI Splicing Prediction Tool.
How many acquisitions has deCODE Genetics made?
deCODE Genetics has made 1 acquisition, including UVS.
Who are deCODE Genetics's investors?
deCODE Genetics has 3 investors. Key investors include Amgen, HHS, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.